当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析 - 利润表

同和药业

(300636)

  

流通市值:22.04亿  总市值:25.20亿
流通股本:3.67亿   总股本:4.20亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入608,217,884.31383,163,489.97184,392,671.37828,659,350.98
  营业收入608,217,884.31383,163,489.97184,392,671.37828,659,350.98
二、营业总成本562,366,220.33357,376,905.98167,876,632.18702,520,673.31
  营业成本438,795,832.54275,395,888.73131,745,065.82577,933,442.86
  税金及附加6,875,702.334,399,014.991,378,782.786,496,304.8
  销售费用20,763,127.5714,049,425.136,186,641.6228,918,363.5
  管理费用32,909,499.5821,582,282.119,863,739.2437,779,917.42
  研发费用54,270,578.4135,962,65315,512,609.1364,993,391.22
  财务费用8,751,479.95,987,642.023,189,793.59-13,600,746.49
  其中:利息费用6,363,392.944,905,128.482,326,673.4312,498,497.27
  其中:利息收入10,890,341.348,884,379.54-25,522,287.79
三、其他经营收益
  加:公允价值变动收益539,726.18191,063.33131,150214,316.67
  加:投资收益-2,618,060.14-1,958,844.06-452,504.61-1,116,706.88
  资产处置收益-63,554.06-63,554.0667,081.06-767,628.83
  资产减值损失(新)-16,356,549.01-9,143,049.19-225,175.73-62,190,491.59
  信用减值损失(新)-2,079,237.17-607,784.46-453,372.53-1,464,805.35
  其他收益8,122,266.915,876,010.494,032,776.5214,081,023.53
四、营业利润33,396,256.6920,080,426.0419,615,993.974,894,385.22
  加:营业外收入532,140.8500,523.56-682,342.22
  减:营业外支出5,076.133,093.3--
五、利润总额33,923,321.3620,577,856.319,615,993.975,576,727.44
  减:所得税费用-4,533,961.5-3,993,126.33836,491.192,485,294.13
六、净利润38,457,282.8624,570,982.6318,779,502.7173,091,433.31
(一)按经营持续性分类
  持续经营净利润38,457,282.8624,570,982.6318,779,502.7173,091,433.31
(二)按所有权归属分类
  归属于母公司股东的净利润38,457,282.8624,570,982.6318,779,502.7173,091,433.31
  扣除非经常损益后的净利润31,666,450.4519,926,972.0816,064,332.5662,744,675.49
七、每股收益
  (一)基本每股收益0.090.060.040.17
  (二)稀释每股收益0.090.060.040.17
九、综合收益总额38,457,282.8624,570,982.6318,779,502.7173,091,433.31
  归属于母公司股东的综合收益总额38,457,282.8624,570,982.6318,779,502.7173,091,433.31
公告日期2026-10-292026-08-262026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑